Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 24.22
-0.42 (-1.70%)
Sep 18, 2026, 3:04 PM CST
SHE:002317 Market Cap
SHE:002317 has a market cap or net worth of 20.59 billion as of September 18, 2026. Its market cap has increased by 21.29% in one year.
Market Cap
20.59B
Enterprise Value
19.28B
Revenue
2.22B
Ranking
n/a
PE Ratio
101.74
Stock Price
24.22
ChartMarket Cap Chart
Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 20.59B, an increase of 185.30%. That is a compound annual growth rate of 6.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 20.59B | 27.61% |
| Dec 31, 2025 | 16.13B | 56.94% |
| Dec 31, 2024 | 10.28B | -24.46% |
| Dec 29, 2023 | 13.61B | -37.64% |
| Dec 30, 2022 | 21.82B | 126.34% |
| Dec 31, 2021 | 9.64B | 8.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.03B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.07B |
| Shanghai Haoyuan Chemexpress | 21.07B |
| Walvax Biotechnology | 20.90B |
| Hybio Pharmaceutical | 20.89B |
| Tasly Pharmaceutical Group | 20.71B |
| Livzon Pharmaceutical Group | 20.65B |
| Jilin Aodong Pharmaceutical Group | 20.29B |